Insider Trading & Ownership - Jenne Kyle

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Jenne Kyle
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-04-16
Sale
2025-04-17
4:53 pm
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
3,016$28.36$85,53447,876
(Direct)
View
2020-09-22
Sale
2020-09-24
4:21 pm
AKCEA THERAPEUTICS INC.AKCAJenne Kyle
Chief Commercial Officer
720$18.12$13,04652,012
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-04-15
Exercise
2025-04-17
4:53 pm
N/A
N/A
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
12,226$047,876
(Direct)
View
2025-01-15
Option Award
2025-01-17
7:40 pm
2028-01-15
N/A
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
46,750$046,750
(Direct)
View
2025-01-02
Option Award
2025-01-06
4:55 pm
2026-01-02
2035-01-01
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
18,700$018,700
(Direct)
View
2024-02-26
Option Award
2024-03-13
5:52 pm
2025-02-26
2034-02-25
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
65,203$065,203
(Direct)
View

Ownership
2024-03-13
5:52 pm
N/A
N/A
IONIS PHARMACEUTICALS INCIONSJenne Kyle
EVP, Chf GL Pdt Str Ofcr
0$01,989
(Direct)
View
2020-10-12
Equity Swap
2020-10-13
3:59 pm
N/A
N/A
AKCEA THERAPEUTICS INC.AKCAJenne Kyle
Chief Commercial Officer
52,012$18.150
(Direct)
View